Safety Study of Attenuated Vaccinia Virus (GL-ONC1)With Combination Therapy in Head & Neck Cancer

Clinical trial NCT01584284 · COMPLETED

Trial details

NCT number: NCT01584284
Sponsor: Genelux Corporation
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Cancer of Head and Neck

Start date: 2012-04-01
Primary completion: 2015-06-01
Enrollment: 19

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.